Using biocrates’ MxP® Quant 1000 kit across MS platforms

Technical note

Our latest technical note confirms the reproducibility and robustness of the MxP® Quant 1000 kit across various MS platforms and labs. High correlation and broad coverage were observed on all instruments. Paired with the AI-powered WebIDQ workflow manager, this solution streamlines data processing and ensures consistent, high-quality results, regardless of the MS system used.

ASMS and Metabolomics 2025

Highlights and takeaways from the biocrates team

This year’s ASMS and Metabolomics 2025 conferences were definite highlights for our team. Both events brought together a vibrant community, fresh ideas, and exciting discussions around metabolomics, multiomics and our new flagship kit, MxP® Quant 1000. Read our blog posts for a closer look at what stood out to us!

🎧 The Metabolomist podcast 🎧

Episode 4 – Metabolomics 2025 feature

This episode features exclusive interviews collected by Alice Limonciel at the 2025 Metabolomics Society conference in Prague, Czech Republic. Across these recordings, you will hear about the small molecules and lipids that make the hearts of ten Metabolomists beat for their research. A big thank you to all the contributors!

Leadership transition at biocrates following Bruker acquisition

Strengthening multiomics innovation through integration and continuity

biocrates life sciences ag has announced a leadership change following its recent acquisition by Bruker Corporation. After five years as CEO, Moritz Seuster will step down, having led the company through a successful digital transformation and the launch of its next-generation metabolomics kit. CMO Sebastian Gottfried has been appointed Site Manager and will oversee the integration with Bruker. Going forward, biocrates will focus on expanding into the multiomics market and driving innovation across mass spectrometry platforms.

biocrates becomes part of Bruker Corporation

A new chapter in quantitative metabolomics

We are excited to share that biocrates life sciences ag has joined Bruker Corporation, marking a major milestone in the evolution of quantitative metabolomics. As a global leader in mass spectrometry-based metabolite and lipid profiling, biocrates will continue to drive innovation and accessibility in multiomics – now with the expanded support and reach of Bruker. This partnership strengthens our shared mission to deliver reproducible, standardized solutions for precision research worldwide.

Transforming medicine with metabolomics

Virtual event | July 15, 2025 | 04:00 pm CEST

Join our upcoming webinar to explore how the MxP® Quant 1000 is driving biomarker discovery and enabling personalized medicine. Experts will present real-world insights from HIV and other studies, highlighting the impact of this powerful kit in clinical research.

MetIDQ support ending soon

Migrate to WebIDQ now

Our legacy software MetIDQ will reach the end of its support lifecycle on December 31, 2025.
If you’re still using MetIDQ, now is the time to migrate to WebIDQ – our cloud-based workflow and analysis software. Click the button for full details and support information.

Transform medicine with metabolomics

Predictive medicine – part 2 of 5

In this five-part blog series, we explore the role of metabolomics in 5P medicine. This second installment highlights how screening samples with broad metabolomics panels and leveraging data with knowledge-driven tools leads to the translation of metabolomics insights into innovative strategies for predictive medicine.

Transform medicine with metabolomics

Preventive medicine – part 1 of 5

Metabolomics is poised to revolutionize medicine through 5P approach, which encompasses preventive, predictive, precise, participatory and population-based healthcare strategies. This first article in a five-part series focuses on prevention, illustrating how metabolomics aids in detecting early disease risks and facilitates personalized lifestyle and dietary interventions.

Strategic collaboration with Platomics

A game-changer for the adoption of metabolomics

We are excited to announce a collaboration with Platomics to streamline metabolomics adoption in laboratories. Integrating biocrates’ kits into the PlatoX® platform simplifies quality assurance, ensuring reproducible results with less effort. Laboratories can seamlessly incorporate regulatory guidance into workflows, from sample preparation to data analysis, accelerating standardized and compliant research.

Partnership to make metabolomics accessible

biovis and biocrates launch personalized health test

With Prevent360, biovis and biocrates enable individuals to monitor 75 key health parameters, backed by personalized recommendations for nutrition, exercise, and overall wellness. This breakthrough reflects our shared passion for innovation and our vision of giving people the knowledge they need to proactively manage their health.